Leticia Laura Niborski
Leticia Laura Niborski
1Institut Curie, PSL Research University, F-75005 Paris, France
2INSERM U932, F-75005 Paris, France
3Translational Research Department, Institut Curie, F-75005 Paris, France
1,2,3,
Paul Gueguen
Paul Gueguen
1Institut Curie, PSL Research University, F-75005 Paris, France
2INSERM U932, F-75005 Paris, France
1,2,
Mengliang Ye
Mengliang Ye
1Institut Curie, PSL Research University, F-75005 Paris, France
2INSERM U932, F-75005 Paris, France
1,2,
Allan Thiolat
Allan Thiolat
4Université Paris-Est, UMR S955, Université Paris-Est Créteil Val de Marne, Créteil, France
5INSERM, U955, Equipe 21, Créteil, France
4,5,
Rodrigo Nalio Ramos
Rodrigo Nalio Ramos
1Institut Curie, PSL Research University, F-75005 Paris, France
2INSERM U932, F-75005 Paris, France
3Translational Research Department, Institut Curie, F-75005 Paris, France
1,2,3,
Pamela Caudana
Pamela Caudana
1Institut Curie, PSL Research University, F-75005 Paris, France
2INSERM U932, F-75005 Paris, France
3Translational Research Department, Institut Curie, F-75005 Paris, France
1,2,3,
Jordan Denizeau
Jordan Denizeau
1Institut Curie, PSL Research University, F-75005 Paris, France
2INSERM U932, F-75005 Paris, France
3Translational Research Department, Institut Curie, F-75005 Paris, France
1,2,3,
Ludovic Colombeau
Ludovic Colombeau
6Institut Curie, PSL Research University, CNRS UMR3666, INSERM U1143, Chemical Biology of Cancer, Equipe Labellisée Ligue contre le Cancer, Paris, France
6,
Raphaël Rodriguez
Raphaël Rodriguez
6Institut Curie, PSL Research University, CNRS UMR3666, INSERM U1143, Chemical Biology of Cancer, Equipe Labellisée Ligue contre le Cancer, Paris, France
6,
Christel Goudot
Christel Goudot
1Institut Curie, PSL Research University, F-75005 Paris, France
2INSERM U932, F-75005 Paris, France
1,2,
Jean-Michel Luccarini
Jean-Michel Luccarini
7Inventiva, 50 rue de Dijon, 21121 Daix, France
7,
Anne Soudé
Anne Soudé
7Inventiva, 50 rue de Dijon, 21121 Daix, France
7,
Bruno Bournique
Bruno Bournique
7Inventiva, 50 rue de Dijon, 21121 Daix, France
7,
Pierre Broqua
Pierre Broqua
7Inventiva, 50 rue de Dijon, 21121 Daix, France
7,
Luigia Pace
Luigia Pace
1Institut Curie, PSL Research University, F-75005 Paris, France
2INSERM U932, F-75005 Paris, France
1,2,
Sylvain Baulande
Sylvain Baulande
8Institut Curie, Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, Paris, France
8,
Christine Sedlik
Christine Sedlik
1Institut Curie, PSL Research University, F-75005 Paris, France
2INSERM U932, F-75005 Paris, France
3Translational Research Department, Institut Curie, F-75005 Paris, France
1,2,3,
Jean-Pierre Quivy
Jean-Pierre Quivy
1Institut Curie, PSL Research University, F-75005 Paris, France
9Institut Curie, PSL Research University, CNRS, UMR3664, Equipe Labellisée Ligue contre le Cancer, Paris, France
10Sorbonne Universités, UPMC University Paris 06, CNRS, UMR3664, F-7005 Paris, France
1,9,10,
Geneviève Almouzni
Geneviève Almouzni
1Institut Curie, PSL Research University, F-75005 Paris, France
9Institut Curie, PSL Research University, CNRS, UMR3664, Equipe Labellisée Ligue contre le Cancer, Paris, France
10Sorbonne Universités, UPMC University Paris 06, CNRS, UMR3664, F-7005 Paris, France
1,9,10,
José L Cohen
José L Cohen
4Université Paris-Est, UMR S955, Université Paris-Est Créteil Val de Marne, Créteil, France
5INSERM, U955, Equipe 21, Créteil, France
4,5,
Elina Zueva
Elina Zueva
1Institut Curie, PSL Research University, F-75005 Paris, France
2INSERM U932, F-75005 Paris, France
1,2,
Joshua J Waterfall
Joshua J Waterfall
1Institut Curie, PSL Research University, F-75005 Paris, France
3Translational Research Department, Institut Curie, F-75005 Paris, France
11INSERM U830, F-75005 Paris, France
1,3,11,
Sebastian Amigorena
Sebastian Amigorena
1Institut Curie, PSL Research University, F-75005 Paris, France
2INSERM U932, F-75005 Paris, France
1,2,✉,#,
Eliane Piaggio
Eliane Piaggio
1Institut Curie, PSL Research University, F-75005 Paris, France
2INSERM U932, F-75005 Paris, France
3Translational Research Department, Institut Curie, F-75005 Paris, France
1,2,3,✉,#
1Institut Curie, PSL Research University, F-75005 Paris, France
2INSERM U932, F-75005 Paris, France
3Translational Research Department, Institut Curie, F-75005 Paris, France
4Université Paris-Est, UMR S955, Université Paris-Est Créteil Val de Marne, Créteil, France
5INSERM, U955, Equipe 21, Créteil, France
6Institut Curie, PSL Research University, CNRS UMR3666, INSERM U1143, Chemical Biology of Cancer, Equipe Labellisée Ligue contre le Cancer, Paris, France
7Inventiva, 50 rue de Dijon, 21121 Daix, France
8Institut Curie, Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, Paris, France
9Institut Curie, PSL Research University, CNRS, UMR3664, Equipe Labellisée Ligue contre le Cancer, Paris, France
10Sorbonne Universités, UPMC University Paris 06, CNRS, UMR3664, F-7005 Paris, France
11INSERM U830, F-75005 Paris, France
Subject terms: Immunotherapy, Cancer immunotherapy, Histone post-translational modifications, Lymphocyte activation
© The Author(s) 2023
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
